Effects of uremic toxins on hippocampal synaptic transmission: implication for neurodegeneration in chronic kidney disease

Patients affected by chronic kidney disease (CKD) have an increased risk of developing cognitive impairment. The cause of mental health disorders in CKD and in chronic hemodialysis patients is multifactorial, due to the interaction of classical cardiovascular disease risk factors, kidney- and dialys...

Celý popis

Uložené v:

Podrobná bibliografia
Vydané v:	Cell death discovery Ročník 7; číslo 1; s. 295 - 6
Hlavní autori:	Natale, Giuseppina, Calabrese, Valeria, Marino, Gioia, Campanelli, Federica, Urciuolo, Federica, de Iure, Antonio, Ghiglieri, Veronica, Calabresi, Paolo, Bossola, Maurizio, Picconi, Barbara
Médium:	Journal Article
Jazyk:	English
Vydavateľské údaje:	London Nature Publishing Group UK 16.10.2021 Springer Nature B.V Nature Publishing Group
Predmet:	631/378/87 692/699/375/364 Apoptosis Astrocytes Biochemistry Biomedical and Life Sciences Cardiovascular diseases Cell Biology Cell Cycle Analysis Cognitive ability Excitatory postsynaptic potentials Glutamatergic transmission Guanidine Hemodialysis Hippocampus Kidney diseases Life Sciences Microglia N-Methyl-D-aspartic acid Neurodegeneration Pyramidal cells Risk factors Stem Cells Synaptic transmission α-Amino-3-hydroxy-5-methyl-4-isoxazole propionic acid γ-Aminobutyric acid γ-Aminobutyric acid receptors
ISSN:	2058-7716, 2058-7716
On-line prístup:	Získať plný text
Tagy:	Pridať tag Žiadne tagy, Buďte prvý, kto otaguje tento záznam!

Abstract	Patients affected by chronic kidney disease (CKD) have an increased risk of developing cognitive impairment. The cause of mental health disorders in CKD and in chronic hemodialysis patients is multifactorial, due to the interaction of classical cardiovascular disease risk factors, kidney- and dialysis-related risk factors with depression, and multiple drugs overuse. A large number of compounds, defined as uremic toxins that normally are excreted by healthy kidneys, accumulate in the circulations, in the tissues, and in the organs of CKD patients. Among the candidate uremic toxins are several guanidino compounds, such as Guanidine. Uremic toxins may also accumulate in the brain and may have detrimental effects on cerebral resident cells (neurons, astrocytes, microglia) and microcirculation. The present study aims to analyze the effect of Guanidine on hippocampal excitatory postsynaptic field potentials (fEPSPs) and in CA1 pyramidal neurons recorded intracellularly. Moreover, we compared these effects with the alterations induced in vitro by CKD patients derived serum samples. Our results show an increased, dose-dependent, synaptic activity in the CA1 area in response to both synthetic Guanidine and patient’s serum, through a mechanism involving glutamatergic transmission. In particular, the concomitant increase of both NMDA and AMPA component of the excitatory postsynaptic currents (EPSCs) suggests a presynaptic mechanism. Interestingly, in presence of the lower dose of guanidine, we measure a significant reduction of EPSCs, in fact the compound does not inhibit GABA receptors allowing their inhibitory effect of glutamate release. These findings suggest that cognitive symptoms induced by the increase of uremic compounds in the serum of CKD patients are caused, at least in part, by an increased glutamatergic transmission in the hippocampus.
AbstractList	Abstract Patients affected by chronic kidney disease (CKD) have an increased risk of developing cognitive impairment. The cause of mental health disorders in CKD and in chronic hemodialysis patients is multifactorial, due to the interaction of classical cardiovascular disease risk factors, kidney- and dialysis-related risk factors with depression, and multiple drugs overuse. A large number of compounds, defined as uremic toxins that normally are excreted by healthy kidneys, accumulate in the circulations, in the tissues, and in the organs of CKD patients. Among the candidate uremic toxins are several guanidino compounds, such as Guanidine. Uremic toxins may also accumulate in the brain and may have detrimental effects on cerebral resident cells (neurons, astrocytes, microglia) and microcirculation. The present study aims to analyze the effect of Guanidine on hippocampal excitatory postsynaptic field potentials (fEPSPs) and in CA1 pyramidal neurons recorded intracellularly. Moreover, we compared these effects with the alterations induced in vitro by CKD patients derived serum samples. Our results show an increased, dose-dependent, synaptic activity in the CA1 area in response to both synthetic Guanidine and patient’s serum, through a mechanism involving glutamatergic transmission. In particular, the concomitant increase of both NMDA and AMPA component of the excitatory postsynaptic currents (EPSCs) suggests a presynaptic mechanism. Interestingly, in presence of the lower dose of guanidine, we measure a significant reduction of EPSCs, in fact the compound does not inhibit GABA receptors allowing their inhibitory effect of glutamate release. These findings suggest that cognitive symptoms induced by the increase of uremic compounds in the serum of CKD patients are caused, at least in part, by an increased glutamatergic transmission in the hippocampus. Patients affected by chronic kidney disease (CKD) have an increased risk of developing cognitive impairment. The cause of mental health disorders in CKD and in chronic hemodialysis patients is multifactorial, due to the interaction of classical cardiovascular disease risk factors, kidney- and dialysis-related risk factors with depression, and multiple drugs overuse. A large number of compounds, defined as uremic toxins that normally are excreted by healthy kidneys, accumulate in the circulations, in the tissues, and in the organs of CKD patients. Among the candidate uremic toxins are several guanidino compounds, such as Guanidine. Uremic toxins may also accumulate in the brain and may have detrimental effects on cerebral resident cells (neurons, astrocytes, microglia) and microcirculation. The present study aims to analyze the effect of Guanidine on hippocampal excitatory postsynaptic field potentials (fEPSPs) and in CA1 pyramidal neurons recorded intracellularly. Moreover, we compared these effects with the alterations induced in vitro by CKD patients derived serum samples. Our results show an increased, dose-dependent, synaptic activity in the CA1 area in response to both synthetic Guanidine and patient's serum, through a mechanism involving glutamatergic transmission. In particular, the concomitant increase of both NMDA and AMPA component of the excitatory postsynaptic currents (EPSCs) suggests a presynaptic mechanism. Interestingly, in presence of the lower dose of guanidine, we measure a significant reduction of EPSCs, in fact the compound does not inhibit GABA receptors allowing their inhibitory effect of glutamate release. These findings suggest that cognitive symptoms induced by the increase of uremic compounds in the serum of CKD patients are caused, at least in part, by an increased glutamatergic transmission in the hippocampus.Patients affected by chronic kidney disease (CKD) have an increased risk of developing cognitive impairment. The cause of mental health disorders in CKD and in chronic hemodialysis patients is multifactorial, due to the interaction of classical cardiovascular disease risk factors, kidney- and dialysis-related risk factors with depression, and multiple drugs overuse. A large number of compounds, defined as uremic toxins that normally are excreted by healthy kidneys, accumulate in the circulations, in the tissues, and in the organs of CKD patients. Among the candidate uremic toxins are several guanidino compounds, such as Guanidine. Uremic toxins may also accumulate in the brain and may have detrimental effects on cerebral resident cells (neurons, astrocytes, microglia) and microcirculation. The present study aims to analyze the effect of Guanidine on hippocampal excitatory postsynaptic field potentials (fEPSPs) and in CA1 pyramidal neurons recorded intracellularly. Moreover, we compared these effects with the alterations induced in vitro by CKD patients derived serum samples. Our results show an increased, dose-dependent, synaptic activity in the CA1 area in response to both synthetic Guanidine and patient's serum, through a mechanism involving glutamatergic transmission. In particular, the concomitant increase of both NMDA and AMPA component of the excitatory postsynaptic currents (EPSCs) suggests a presynaptic mechanism. Interestingly, in presence of the lower dose of guanidine, we measure a significant reduction of EPSCs, in fact the compound does not inhibit GABA receptors allowing their inhibitory effect of glutamate release. These findings suggest that cognitive symptoms induced by the increase of uremic compounds in the serum of CKD patients are caused, at least in part, by an increased glutamatergic transmission in the hippocampus. Patients affected by chronic kidney disease (CKD) have an increased risk of developing cognitive impairment. The cause of mental health disorders in CKD and in chronic hemodialysis patients is multifactorial, due to the interaction of classical cardiovascular disease risk factors, kidney- and dialysis-related risk factors with depression, and multiple drugs overuse. A large number of compounds, defined as uremic toxins that normally are excreted by healthy kidneys, accumulate in the circulations, in the tissues, and in the organs of CKD patients. Among the candidate uremic toxins are several guanidino compounds, such as Guanidine. Uremic toxins may also accumulate in the brain and may have detrimental effects on cerebral resident cells (neurons, astrocytes, microglia) and microcirculation. The present study aims to analyze the effect of Guanidine on hippocampal excitatory postsynaptic field potentials (fEPSPs) and in CA1 pyramidal neurons recorded intracellularly. Moreover, we compared these effects with the alterations induced in vitro by CKD patients derived serum samples. Our results show an increased, dose-dependent, synaptic activity in the CA1 area in response to both synthetic Guanidine and patient’s serum, through a mechanism involving glutamatergic transmission. In particular, the concomitant increase of both NMDA and AMPA component of the excitatory postsynaptic currents (EPSCs) suggests a presynaptic mechanism. Interestingly, in presence of the lower dose of guanidine, we measure a significant reduction of EPSCs, in fact the compound does not inhibit GABA receptors allowing their inhibitory effect of glutamate release. These findings suggest that cognitive symptoms induced by the increase of uremic compounds in the serum of CKD patients are caused, at least in part, by an increased glutamatergic transmission in the hippocampus.
ArticleNumber	295
Author	Calabresi, Paolo Picconi, Barbara Calabrese, Valeria Campanelli, Federica Marino, Gioia de Iure, Antonio Bossola, Maurizio Urciuolo, Federica Ghiglieri, Veronica Natale, Giuseppina
Author_xml	– sequence: 1 givenname: Giuseppina surname: Natale fullname: Natale, Giuseppina organization: Dipartimento di Neuroscienze, Neurology Unit, Università Cattolica del Sacro Cuore, Department of Medicine, University of Perugia – sequence: 2 givenname: Valeria surname: Calabrese fullname: Calabrese, Valeria organization: Department of Medicine, University of Perugia, Laboratory of Experimental Neurophysiology, IRCCS San Raffaele Roma – sequence: 3 givenname: Gioia surname: Marino fullname: Marino, Gioia organization: Dipartimento di Neuroscienze, Neurology Unit, Università Cattolica del Sacro Cuore, Department of Medicine, University of Perugia – sequence: 4 givenname: Federica surname: Campanelli fullname: Campanelli, Federica organization: Dipartimento di Neuroscienze, Neurology Unit, Università Cattolica del Sacro Cuore – sequence: 5 givenname: Federica surname: Urciuolo fullname: Urciuolo, Federica organization: Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Hemodialysis Unit, Division of Nephrology, Università Cattolica del Sacro Cuore – sequence: 6 givenname: Antonio surname: de Iure fullname: de Iure, Antonio organization: Laboratory of Experimental Neurophysiology, IRCCS San Raffaele Roma – sequence: 7 givenname: Veronica surname: Ghiglieri fullname: Ghiglieri, Veronica organization: Telematic University San Raffaele – sequence: 8 givenname: Paolo surname: Calabresi fullname: Calabresi, Paolo organization: Dipartimento di Neuroscienze, Neurology Unit, Università Cattolica del Sacro Cuore, Fondazione Policlinico Universitario Agostino Gemelli IRCCS – sequence: 9 givenname: Maurizio orcidid: 0000-0003-1627-0235 surname: Bossola fullname: Bossola, Maurizio email: maurizio.bossola@policlinicogemelli.it organization: Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Hemodialysis Unit, Division of Nephrology, Università Cattolica del Sacro Cuore – sequence: 10 givenname: Barbara orcidid: 0000-0001-6020-1021 surname: Picconi fullname: Picconi, Barbara email: barbara.picconi@uniroma5.it organization: Laboratory of Experimental Neurophysiology, IRCCS San Raffaele Roma, Telematic University San Raffaele
BookMark	eNp9Uk1v1DAUtFARLUv_AKdIXLgE_Bk7HJBQVaBSJS5wthzneddLYgc7QSy_Hu-mCNpDT7bfmxn7jec5OgsxAEIvCX5DMFNvMyec4hpTUmPcKFG3T9AFxULVUpLm7L_9ObrMeY8xJkJyqdgzdM54IySh9AL9vnYO7Jyr6KolwehtNcdfPpRCqHZ-mqI142SGKh-CmeZjO5mQR5-zj-Fd5cdp8NbM5VC5mKoAS4o9bCFAWqs-VHaXYijU774PcKh6n8FkeIGeOjNkuLxbN-jbx-uvV5_r2y-fbq4-3NZWEDnXoleipUYQIL0UqiHEWKVcwwkzFHfcdgJw64x1xEiGHe-cMLJrG162wCXboJtVt49mr6fkR5MOOhqvT4WYttqkMtkAGgvMObct7aHnHSZKKNU54gh1UlJmitb7VWtauhF6C6HYMdwTvd8Jfqe38adWovwH40Xg9Z1Aij8WyLMuVloYBhMgLllToRijsqGqQF89gO7jkkKx6oiiXBFZPNggtaJsijkncNr6-eR8ud8PmmB9zIte86JLXvQpL7otVPqA-neOR0lsJeUCDltI_171COsPm93Vig
CitedBy_id	crossref_primary_10_1093_ndt_gfad244 crossref_primary_10_3389_fmed_2024_1397160 crossref_primary_10_1080_25742442_2022_2036538 crossref_primary_10_1002_advs_202404166 crossref_primary_10_1007_s12070_024_04586_y crossref_primary_10_1038_s41598_024_77094_2 crossref_primary_10_1002_aisy_202300754 crossref_primary_10_1016_j_neurobiolaging_2023_05_014 crossref_primary_10_1007_s40620_024_01929_4 crossref_primary_10_3390_jcm12041459 crossref_primary_10_1053_j_ajkd_2025_01_007 crossref_primary_10_1093_ndt_gfac263 crossref_primary_10_3390_ijms241512168 crossref_primary_10_1136_jnis_2025_023756
Cites_doi	10.1016/0006-8993(92)90200-S 10.1002/ana.410280505 10.1111/j.1525-139X.2009.00577.x 10.1186/2045-8118-8-13 10.1016/0009-8981(87)90088-X 10.1016/j.biopsych.2009.11.008 10.1146/annurev.physiol.64.092501.114547 10.1093/brain/awh190 10.1038/nrneph.2010.83 10.1053/j.ajkd.2015.12.028 10.1523/JNEUROSCI.17-12-04509.1997 10.1093/ndt/gft327 10.1016/j.expneurol.2012.03.020 10.1053/j.ajkd.2019.05.017 10.1016/S0304-3940(99)00190-1 10.1159/000452603 10.1046/j.1523-1755.2001.59780077.x 10.1016/0028-3908(96)00011-1 10.1681/ASN.2012050536 10.1523/JNEUROSCI.14-09-05325.1994 10.1523/JNEUROSCI.2149-10.2010 10.1046/j.1523-1755.2003.00924.x 10.1152/jn.1993.70.4.1451 10.1002/ana.410300419 10.1159/000188511 10.1016/0197-0186(95)00041-6 10.1002/14651858.CD010699.pub2 10.3390/toxins10070303
ContentType	Journal Article
Copyright	The Author(s) 2021 The Author(s) 2021. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. 2021. The Author(s).
Copyright_xml	– notice: The Author(s) 2021 – notice: The Author(s) 2021. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. – notice: 2021. The Author(s).
DBID	C6C AAYXX CITATION 3V. 7X7 7XB 8FE 8FH 8FI 8FJ 8FK ABUWG AFKRA AZQEC BBNVY BENPR BHPHI CCPQU DWQXO FYUFA GHDGH GNUQQ HCIFZ K9. LK8 M0S M7P PHGZM PHGZT PJZUB PKEHL PPXIY PQEST PQGLB PQQKQ PQUKI PRINS 7X8 5PM DOA
DOI	10.1038/s41420-021-00685-9
DatabaseName	Springer Nature OA Free Journals CrossRef ProQuest Central (Corporate) Health & Medical Collection ProQuest Central (purchase pre-March 2016) ProQuest SciTech Collection ProQuest Natural Science Collection Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest Central UK/Ireland ProQuest Central Essentials - QC Biological Science Collection ProQuest Central Natural Science Collection ProQuest One ProQuest Central Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Central Student SciTech Premium Collection ProQuest Health & Medical Complete (Alumni) Biological Sciences ProQuest Health & Medical Collection Biological Science Database ProQuest Central Premium ProQuest One Academic ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) One Applied & Life Sciences ProQuest One Academic (retired) ProQuest One Academic UKI Edition ProQuest Central China MEDLINE - Academic PubMed Central (Full Participant titles) DOAJ Directory of Open Access Journals
DatabaseTitle	CrossRef ProQuest Central Student ProQuest One Academic Middle East (New) ProQuest Central Essentials ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) SciTech Premium Collection ProQuest One Community College ProQuest One Health & Nursing ProQuest Natural Science Collection ProQuest Central China ProQuest Central ProQuest One Applied & Life Sciences ProQuest Health & Medical Research Collection Health Research Premium Collection Health and Medicine Complete (Alumni Edition) Natural Science Collection ProQuest Central Korea Biological Science Collection ProQuest Central (New) ProQuest Biological Science Collection ProQuest One Academic Eastern Edition ProQuest Hospital Collection Health Research Premium Collection (Alumni) Biological Science Database ProQuest SciTech Collection ProQuest Hospital Collection (Alumni) ProQuest Health & Medical Complete ProQuest One Academic UKI Edition ProQuest One Academic ProQuest Central (Alumni) ProQuest One Academic (New) MEDLINE - Academic
DatabaseTitleList	MEDLINE - Academic CrossRef ProQuest Central Student
Database_xml	– sequence: 1 dbid: DOA name: DOAJ Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: BENPR name: ProQuest Central url: https://www.proquest.com/central sourceTypes: Aggregation Database
DeliveryMethod	fulltext_linktorsrc
Discipline	Biology
EISSN	2058-7716
EndPage	6
ExternalDocumentID	oai_doaj_org_article_050444c92ded4b018588bf1f12f7723a PMC8520534 10_1038_s41420_021_00685_9
GroupedDBID	0R~ 3V. 53G 7X7 8FE 8FH 8FI 8FJ AAFWJ AAJSJ ABUWG ACSMW ADBBV ADRAZ AFKRA AFPKN AJTQC ALIPV ALMA_UNASSIGNED_HOLDINGS AOIJS BBNVY BCNDV BENPR BHPHI BPHCQ BVXVI C6C CCPQU EBLON EBS EMOBN FYUFA GROUPED_DOAJ HCIFZ HMCUK HYE LK8 M48 M7P M~E NAO OK1 PGMZT PQQKQ PROAC RNT RPM SNYQT UKHRP AASML AAYXX CITATION 7XB 8FK AZQEC DWQXO GNUQQ K9. PHGZM PHGZT PJZUB PKEHL PPXIY PQEST PQGLB PQUKI PRINS 7X8 PUEGO 5PM
ID	FETCH-LOGICAL-c517t-5d8592a51e1d758611ac88f6413a20b4cb5e09facf1a730f4bf5a7b964f4be473
IEDL.DBID	DOA
ISICitedReferencesCount	13
ISICitedReferencesURI	http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000708225200002&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
ISSN	2058-7716
IngestDate	Fri Oct 03 12:52:21 EDT 2025 Tue Nov 04 01:56:12 EST 2025 Fri Sep 05 10:45:04 EDT 2025 Tue Oct 07 07:00:27 EDT 2025 Tue Nov 18 22:35:16 EST 2025 Sat Nov 29 03:44:01 EST 2025 Fri Feb 21 02:37:19 EST 2025
IsDoiOpenAccess	true
IsOpenAccess	true
IsPeerReviewed	true
IsScholarly	true
Issue	1
Language	English
License	Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
LinkModel	DirectLink
MergedId	FETCHMERGED-LOGICAL-c517t-5d8592a51e1d758611ac88f6413a20b4cb5e09facf1a730f4bf5a7b964f4be473
Notes	ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23
ORCID	0000-0001-6020-1021 0000-0003-1627-0235
OpenAccessLink	https://doaj.org/article/050444c92ded4b018588bf1f12f7723a
PMID	34657122
PQID	2582481741
PQPubID	2041962
PageCount	6
ParticipantIDs	doaj_primary_oai_doaj_org_article_050444c92ded4b018588bf1f12f7723a pubmedcentral_primary_oai_pubmedcentral_nih_gov_8520534 proquest_miscellaneous_2583327628 proquest_journals_2582481741 crossref_citationtrail_10_1038_s41420_021_00685_9 crossref_primary_10_1038_s41420_021_00685_9 springer_journals_10_1038_s41420_021_00685_9
PublicationCentury	2000
PublicationDate	2021-10-16
PublicationDateYYYYMMDD	2021-10-16
PublicationDate_xml	– month: 10 year: 2021 text: 2021-10-16 day: 16
PublicationDecade	2020
PublicationPlace	London
PublicationPlace_xml	– name: London – name: New York
PublicationTitle	Cell death discovery
PublicationTitleAbbrev	Cell Death Discov
PublicationYear	2021
Publisher	Nature Publishing Group UK Springer Nature B.V Nature Publishing Group
Publisher_xml	– name: Nature Publishing Group UK – name: Springer Nature B.V – name: Nature Publishing Group
References	De Deyn, D'Hooge, Van Bogaert, Marescau (CR16) 2001; 78 Sgobio, Ghiglieri, Costa, Bagetta, Siliquini, Barone (CR28) 2010; 67 Tachikawa, Hosoya (CR19) 2011; 8 O'Lone, Connors, Masson, Wu, Kelly, Gillespie (CR1) 2016; 67 De Deyn, Marescau, D'Hooge, Possemiers, Nagler, Mahler (CR6) 1995; 27 Topczewska-Bruns, Tankiewicz, Pawlak, Buczko (CR14) 2001; 53 Calabresi, Centonze, Pisani, Bernardi (CR24) 1997; 17 De Deyn, Macdonald (CR15) 1990; 28 Picconi, Centonze, Rossi, Bernardi, Calabresi (CR25) 2004; 127 Pi, Xu, Xu, Yang, Qu, Chen (CR3) 2016; 41 Manabe, Wyllie, Perkel, Nicoll (CR22) 1993; 70 Schulz, Cook, Johnston (CR23) 1994; 14 Paille, Picconi, Bagetta, Ghiglieri, Sgobio, Di Filippo (CR29) 2010; 30 D'Hooge, Pei, Manil, De, Deyn (CR13) 1992; 598 D'Hooge, Manil, Colin, De Deyn (CR11) 1991; 30 CR4 CR7 Ballesta, del Pozo, Castello-Banyuls, Faura (CR8) 2012; 236 D'Hooge, Raes, Lebrun, Diltoer, Van Bogaert, Manil (CR12) 1996; 35 Bugnicourt, Godefroy, Chillon, Choukroun, Massy (CR18) 2013; 24 D'Hooge, De Deyn, Van de Vijver, Antoons, Raes, Van, Bogaert (CR10) 1999; 265 Vanholder, De Smet, Glorieux, Argiles, Baurmeister, Brunet (CR5) 2003; 63 McQuillan, Jassal (CR17) 2010; 6 Drew, Weiner, Sarnak (CR2) 2019; 74 De Deyn, Robitaille, Vanasse, Qureshi, Marescau (CR21) 1995; 69 De Deyn, Vanholder, Eloot, Glorieux (CR27) 2009; 22 Zucker, Regehr (CR26) 2002; 64 Fujisaki, Tsuruya, Yamato, Toyonaga, Noguchi, Nakano (CR9) 2014; 29 De Deyn, Marescau, Cuykens, Van Gorp, Lowenthal, De Potter (CR20) 1987; 167 E O'Lone (685_CR1) 2016; 67 PP De Deyn (685_CR6) 1995; 27 PP De Deyn (685_CR15) 1990; 28 PP De Deyn (685_CR16) 2001; 78 PP De Deyn (685_CR27) 2009; 22 R Vanholder (685_CR5) 2003; 63 K Fujisaki (685_CR9) 2014; 29 PE Schulz (685_CR23) 1994; 14 V Paille (685_CR29) 2010; 30 RS Zucker (685_CR26) 2002; 64 DA Drew (685_CR2) 2019; 74 B Picconi (685_CR25) 2004; 127 J Topczewska-Bruns (685_CR14) 2001; 53 HC Pi (685_CR3) 2016; 41 JM Bugnicourt (685_CR18) 2013; 24 P Calabresi (685_CR24) 1997; 17 C Sgobio (685_CR28) 2010; 67 R D'Hooge (685_CR11) 1991; 30 685_CR7 PP De Deyn (685_CR20) 1987; 167 M Tachikawa (685_CR19) 2011; 8 R McQuillan (685_CR17) 2010; 6 685_CR4 R D'Hooge (685_CR13) 1992; 598 JJ Ballesta (685_CR8) 2012; 236 R D'Hooge (685_CR12) 1996; 35 T Manabe (685_CR22) 1993; 70 R D'Hooge (685_CR10) 1999; 265 PP De Deyn (685_CR21) 1995; 69
References_xml	– volume: 598 start-page: 316 year: 1992 end-page: 20 ident: CR13 article-title: The uremic guanidino compound guanidinosuccinic acid induces behavioral convulsions and concomitant epileptiform electrocorticographic discharges in mice publication-title: Brain Res doi: 10.1016/0006-8993(92)90200-S – volume: 53 start-page: 263 year: 2001 end-page: 9 ident: CR14 article-title: Behavioral changes in the course of chronic renal insufficiency in rats publication-title: Pol J Pharm – volume: 28 start-page: 627 year: 1990 end-page: 33 ident: CR15 article-title: Guanidino compounds that are increased in cerebrospinal fluid and brain of uremic patients inhibit GABA and glycine responses on mouse neurons in cell culture publication-title: Ann Neurol doi: 10.1002/ana.410280505 – volume: 22 start-page: 340 year: 2009 end-page: 5 ident: CR27 article-title: Guanidino compounds as uremic (neuro)toxins publication-title: Semin Dial doi: 10.1111/j.1525-139X.2009.00577.x – volume: 8 start-page: 13 year: 2011 ident: CR19 article-title: Transport characteristics of guanidino compounds at the blood-brain barrier and blood-cerebrospinal fluid barrier: relevance to neural disorders publication-title: Fluids Barriers CNS doi: 10.1186/2045-8118-8-13 – volume: 167 start-page: 81 year: 1987 end-page: 8 ident: CR20 article-title: Guanidino compounds in serum and cerebrospinal fluid of non-dialyzed patients with renal insufficiency publication-title: Clin Chim Acta doi: 10.1016/0009-8981(87)90088-X – volume: 67 start-page: 567 year: 2010 end-page: 74 ident: CR28 article-title: Hippocampal synaptic plasticity, memory, and epilepsy: effects of long-term valproic acid treatment publication-title: Biol Psychiatry doi: 10.1016/j.biopsych.2009.11.008 – volume: 64 start-page: 355 year: 2002 end-page: 405 ident: CR26 article-title: Short-term synaptic plasticity publication-title: Annu Rev Physiol doi: 10.1146/annurev.physiol.64.092501.114547 – volume: 127 start-page: 1661 year: 2004 end-page: 9 ident: CR25 article-title: Therapeutic doses of L-dopa reverse hypersensitivity of corticostriatal D2-dopamine receptors and glutamatergic overactivity in experimental parkinsonism publication-title: Brain doi: 10.1093/brain/awh190 – ident: CR4 – volume: 6 start-page: 471 year: 2010 end-page: 9 ident: CR17 article-title: Neuropsychiatric complications of chronic kidney disease publication-title: Nat Rev Nephrol doi: 10.1038/nrneph.2010.83 – volume: 67 start-page: 925 year: 2016 end-page: 35 ident: CR1 article-title: Cognition in people with end-stage kidney disease treated with hemodialysis: a systematic review and meta-analysis publication-title: Am J Kidney Dis doi: 10.1053/j.ajkd.2015.12.028 – volume: 17 start-page: 4509 year: 1997 end-page: 16 ident: CR24 article-title: Endogenous adenosine mediates the presynaptic inhibition induced by aglycemia at corticostriatal synapses publication-title: J Neurosci doi: 10.1523/JNEUROSCI.17-12-04509.1997 – volume: 29 start-page: 529 year: 2014 end-page: 38 ident: CR9 article-title: Cerebral oxidative stress induces spatial working memory dysfunction in uremic mice: neuroprotective effect of tempol publication-title: Nephrol Dial Transpl doi: 10.1093/ndt/gft327 – volume: 236 start-page: 28 year: 2012 end-page: 33 ident: CR8 article-title: Selective down-regulation of alpha4beta2 neuronal nicotinic acetylcholine receptors in the brain of uremic rats with cognitive impairment publication-title: Exp Neurol doi: 10.1016/j.expneurol.2012.03.020 – volume: 74 start-page: 782 year: 2019 end-page: 90 ident: CR2 article-title: Cognitive impairment in CKD: pathophysiology, management, and prevention publication-title: Am J Kidney Dis doi: 10.1053/j.ajkd.2019.05.017 – volume: 265 start-page: 83 year: 1999 end-page: 6 ident: CR10 article-title: Uraemic guanidino compounds inhibit gamma-aminobutyric acid-evoked whole cell currents in mouse spinal cord neurones publication-title: Neurosci Lett doi: 10.1016/S0304-3940(99)00190-1 – volume: 41 start-page: 986 year: 2016 end-page: 96 ident: CR3 article-title: Cognitive impairment and structural neuroimaging abnormalities among patients with chronic kidney disease publication-title: Kidney Blood Press Res doi: 10.1159/000452603 – volume: 78 start-page: S77 year: 2001 end-page: 83 ident: CR16 article-title: Endogenous guanidino compounds as uremic neurotoxins publication-title: Kidney Int Suppl doi: 10.1046/j.1523-1755.2001.59780077.x – volume: 35 start-page: 433 year: 1996 end-page: 40 ident: CR12 article-title: N-methyl-D-aspartate receptor activation by guanidinosuccinate but not by methylguanidine: behavioural and electrophysiological evidence publication-title: Neuropharmacology doi: 10.1016/0028-3908(96)00011-1 – volume: 24 start-page: 353 year: 2013 end-page: 63 ident: CR18 article-title: Cognitive disorders and dementia in CKD: the neglected kidney-brain axis publication-title: J Am Soc Nephrol doi: 10.1681/ASN.2012050536 – volume: 14 start-page: 5325 year: 1994 end-page: 37 ident: CR23 article-title: Changes in paired-pulse facilitation suggest presynaptic involvement in long-term potentiation publication-title: J Neurosci doi: 10.1523/JNEUROSCI.14-09-05325.1994 – volume: 30 start-page: 14182 year: 2010 end-page: 93 ident: CR29 article-title: Distinct levels of dopamine denervation differentially alter striatal synaptic plasticity and NMDA receptor subunit composition publication-title: J Neurosci doi: 10.1523/JNEUROSCI.2149-10.2010 – volume: 63 start-page: 1934 year: 2003 end-page: 43 ident: CR5 article-title: Review on uremic toxins: classification, concentration, and interindividual variability publication-title: Kidney Int doi: 10.1046/j.1523-1755.2003.00924.x – volume: 70 start-page: 1451 year: 1993 end-page: 9 ident: CR22 article-title: Modulation of synaptic transmission and long-term potentiation: effects on paired pulse facilitation and EPSC variance in the CA1 region of the hippocampus publication-title: J Neurophysiol doi: 10.1152/jn.1993.70.4.1451 – ident: CR7 – volume: 30 start-page: 622 year: 1991 end-page: 3 ident: CR11 article-title: Guanidinosuccinic acid inhibits excitatory synaptic transmission in CA1 region of rat hippocampal slices publication-title: Ann Neurol doi: 10.1002/ana.410300419 – volume: 69 start-page: 411 year: 1995 end-page: 7 ident: CR21 article-title: Serum guanidino compound levels in uremic pediatric patients treated with hemodialysis or continuous cycle peritoneal dialysis. Correlations between nerve conduction velocities and altered guanidino compound concentrations publication-title: Nephron doi: 10.1159/000188511 – volume: 27 start-page: 227 year: 1995 end-page: 37 ident: CR6 article-title: Guanidino compound levels in brain regions of non-dialyzed uremic patients publication-title: Neurochem Int doi: 10.1016/0197-0186(95)00041-6 – volume: 24 start-page: 353 year: 2013 ident: 685_CR18 publication-title: J Am Soc Nephrol doi: 10.1681/ASN.2012050536 – volume: 22 start-page: 340 year: 2009 ident: 685_CR27 publication-title: Semin Dial doi: 10.1111/j.1525-139X.2009.00577.x – volume: 53 start-page: 263 year: 2001 ident: 685_CR14 publication-title: Pol J Pharm – ident: 685_CR4 doi: 10.1002/14651858.CD010699.pub2 – volume: 29 start-page: 529 year: 2014 ident: 685_CR9 publication-title: Nephrol Dial Transpl doi: 10.1093/ndt/gft327 – volume: 127 start-page: 1661 year: 2004 ident: 685_CR25 publication-title: Brain doi: 10.1093/brain/awh190 – volume: 598 start-page: 316 year: 1992 ident: 685_CR13 publication-title: Brain Res doi: 10.1016/0006-8993(92)90200-S – volume: 67 start-page: 567 year: 2010 ident: 685_CR28 publication-title: Biol Psychiatry doi: 10.1016/j.biopsych.2009.11.008 – volume: 30 start-page: 14182 year: 2010 ident: 685_CR29 publication-title: J Neurosci doi: 10.1523/JNEUROSCI.2149-10.2010 – volume: 6 start-page: 471 year: 2010 ident: 685_CR17 publication-title: Nat Rev Nephrol doi: 10.1038/nrneph.2010.83 – volume: 70 start-page: 1451 year: 1993 ident: 685_CR22 publication-title: J Neurophysiol doi: 10.1152/jn.1993.70.4.1451 – volume: 63 start-page: 1934 year: 2003 ident: 685_CR5 publication-title: Kidney Int doi: 10.1046/j.1523-1755.2003.00924.x – volume: 64 start-page: 355 year: 2002 ident: 685_CR26 publication-title: Annu Rev Physiol doi: 10.1146/annurev.physiol.64.092501.114547 – volume: 8 start-page: 13 year: 2011 ident: 685_CR19 publication-title: Fluids Barriers CNS doi: 10.1186/2045-8118-8-13 – volume: 74 start-page: 782 year: 2019 ident: 685_CR2 publication-title: Am J Kidney Dis doi: 10.1053/j.ajkd.2019.05.017 – volume: 28 start-page: 627 year: 1990 ident: 685_CR15 publication-title: Ann Neurol doi: 10.1002/ana.410280505 – volume: 27 start-page: 227 year: 1995 ident: 685_CR6 publication-title: Neurochem Int doi: 10.1016/0197-0186(95)00041-6 – volume: 17 start-page: 4509 year: 1997 ident: 685_CR24 publication-title: J Neurosci doi: 10.1523/JNEUROSCI.17-12-04509.1997 – volume: 67 start-page: 925 year: 2016 ident: 685_CR1 publication-title: Am J Kidney Dis doi: 10.1053/j.ajkd.2015.12.028 – volume: 69 start-page: 411 year: 1995 ident: 685_CR21 publication-title: Nephron doi: 10.1159/000188511 – volume: 41 start-page: 986 year: 2016 ident: 685_CR3 publication-title: Kidney Blood Press Res doi: 10.1159/000452603 – ident: 685_CR7 doi: 10.3390/toxins10070303 – volume: 265 start-page: 83 year: 1999 ident: 685_CR10 publication-title: Neurosci Lett doi: 10.1016/S0304-3940(99)00190-1 – volume: 236 start-page: 28 year: 2012 ident: 685_CR8 publication-title: Exp Neurol doi: 10.1016/j.expneurol.2012.03.020 – volume: 167 start-page: 81 year: 1987 ident: 685_CR20 publication-title: Clin Chim Acta doi: 10.1016/0009-8981(87)90088-X – volume: 14 start-page: 5325 year: 1994 ident: 685_CR23 publication-title: J Neurosci doi: 10.1523/JNEUROSCI.14-09-05325.1994 – volume: 35 start-page: 433 year: 1996 ident: 685_CR12 publication-title: Neuropharmacology doi: 10.1016/0028-3908(96)00011-1 – volume: 30 start-page: 622 year: 1991 ident: 685_CR11 publication-title: Ann Neurol doi: 10.1002/ana.410300419 – volume: 78 start-page: S77 year: 2001 ident: 685_CR16 publication-title: Kidney Int Suppl doi: 10.1046/j.1523-1755.2001.59780077.x
SSID	ssj0001574783
Score	2.245766
Snippet	Patients affected by chronic kidney disease (CKD) have an increased risk of developing cognitive impairment. The cause of mental health disorders in CKD and in... Abstract Patients affected by chronic kidney disease (CKD) have an increased risk of developing cognitive impairment. The cause of mental health disorders in...
SourceID	doaj pubmedcentral proquest crossref springer
SourceType	Open Website Open Access Repository Aggregation Database Enrichment Source Index Database Publisher
StartPage	295
SubjectTerms	631/378/87 692/699/375/364 Apoptosis Astrocytes Biochemistry Biomedical and Life Sciences Cardiovascular diseases Cell Biology Cell Cycle Analysis Cognitive ability Excitatory postsynaptic potentials Glutamatergic transmission Guanidine Hemodialysis Hippocampus Kidney diseases Life Sciences Microglia N-Methyl-D-aspartic acid Neurodegeneration Pyramidal cells Risk factors Stem Cells Synaptic transmission α-Amino-3-hydroxy-5-methyl-4-isoxazole propionic acid γ-Aminobutyric acid γ-Aminobutyric acid receptors
SummonAdditionalLinks	– databaseName: Biological Science Database dbid: M7P link: http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1Lb9QwELaggMSFNyJQkJG4QdT4ldhcECAqDqjqAaTeLMex26iVs2y2iOXXM3a8u0oleuEW2U7i6LNnxjOTbxB6AxYEdBFTGmdMyRupylZ1pBQdt8zXxnmXSFy_NUdH8uREHWeH25jTKjcyMQnqbrDRR35AhaRcgv1MPix-lrFqVIyu5hIaN9GtyJLAUure8c7HIiI7PMv_ylRMHoyccDgvxbyE-HOEKNVMHyXa_pmteTVT8kq4NGmhw_v_O_8H6F62P_HHacE8RDdceITuTBUp14_Rn4nNeMSDx9F12Fu8Gn73ARoCPusXC1B9IEAu8LgOBqQNdEdlB4slet3e436XoI7BHMaJLrNzp4ncOrX2AduJkBef911wa5xjRE_Qj8Mv3z9_LXN5htIK0qwATikUNYI40sGpoybEWCl9DWrR0KrlthWuUt5YTwzIEc9bL0zTqprDpeMNe4r2whDcM4TjKaxVyrhICMisVfDUSlWWemOUsqZAZAOStpm7PJbQuNAphs6knoDVAKxOwGpVoLfbexYTc8e1oz9F7LcjI-t2ahiWpzpvYl2JyK5nFe1cx9sKTB0pW088oR4OKQymub_BXmdRMOod8AV6ve0GXGJkxgQ3XKYxjFHQS7JAzWzFzSY07wn9WaIDl4KCJOUFerdZm7uX__uDn18_1xfoLo27JObu1Ptob7W8dC_Rbftr1Y_LV2mb_QW8_DLf priority: 102 providerName: ProQuest
Title	Effects of uremic toxins on hippocampal synaptic transmission: implication for neurodegeneration in chronic kidney disease
URI	https://link.springer.com/article/10.1038/s41420-021-00685-9 https://www.proquest.com/docview/2582481741 https://www.proquest.com/docview/2583327628 https://pubmed.ncbi.nlm.nih.gov/PMC8520534 https://doaj.org/article/050444c92ded4b018588bf1f12f7723a
Volume	7
WOSCitedRecordID	wos000708225200002&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
hasFullText	1
inHoldings	1
isFullTextHit
isPrint
journalDatabaseRights	– providerCode: PRVAON databaseName: DOAJ Directory of Open Access Journals customDbUrl: eissn: 2058-7716 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0001574783 issn: 2058-7716 databaseCode: DOA dateStart: 20150101 isFulltext: true titleUrlDefault: https://www.doaj.org/ providerName: Directory of Open Access Journals – providerCode: PRVHPJ databaseName: ROAD: Directory of Open Access Scholarly Resources customDbUrl: eissn: 2058-7716 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0001574783 issn: 2058-7716 databaseCode: M~E dateStart: 20150101 isFulltext: true titleUrlDefault: https://road.issn.org providerName: ISSN International Centre
link	http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3dj9QgEJ_oqYkvxs9YPTeY-KbNFQpb8M0ze_HBbDZGk30jlILXeGE31z3j-uDf7kC7e9dL1BdfSMPQFpiBmYHhB8ArtCCQRE1unDE5r6TKa9XQXDTcln5qnHcJxPVjNZ_L5VItrlz1FWPCenjgvuOOChERzaxijWt4XaB6kbL21FPm0TAsk2mEVs8VZ6o_Hxxx4cvhlExRyqOOU46eUoxIiMciRK5GmigB9o-szOsxktc2SpP-ObkP9wbDkbzrK_wAbrjwEO70V0luH8HPHoa4IytP4ppfa8lm9aMNmBHIabteo87CkX9Gum0wOE0gOWop5HJcLntL2svIcoJ2LEk4l437mlCpU24biO2RdMm3tgluS4bNncfw5WT2-f2HfLhXIbeCVhvkgxSKGUEdbdBdmFJqrJR-ivrMsKLmthauUN5YTw1OAJ7XXpiqVlOOj45X5RM4CKvgngKJ7lOtlHERya-0VuFXC1VY5o1RypoM6K6PtR1Ax-PdF2c6bX6XUvd80cgXnfiiVQav9--se8iNv5Y-jqzbl4xw2SkDhUgPQqT_JUQZHO4Yr4cx3GkmJOMSPTaawcs9GfkSt1RMcKuLVKYsGSoUmUE1EphRhcaU0J4mHG8pGE6BPIM3O9G6_PmfG_zsfzT4OdxlcSjE0JzpIRxszi_cC7htv2_a7nwCN6tllVI5gVvHs_ni0ySNr0kMjV3E9NfsN6PLKaE
linkProvider	Directory of Open Access Journals
linkToHtml	http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V3LbtQwFLVKAcGGNyJQwEiwgqixY09sJIR4Va06jFgUaXau49htRJUMkykwfBTfyLWTzCiV6K4LdpHtJHZy7sP29bkIPQcPAqqIjrXVOmaZkHEuCxLzgpnUjbR1NpC4jrPJREyn8ssG-tOfhfFhlb1ODIq6qI1fI9-mXFAmwH8mb2ffY581yu-u9ik0Wljs2-VPmLI1b_Y-wv99QenOp4MPu3GXVSA2nGQL6IXgkmpOLCnAWR4Roo0QbgTaXNMkZybnNpFOG0c0wN-x3HGd5XLE4NKyLIXnXkKXQY9nPoQsm2brNR3u2ejT7mxOkorthhEG8zMfB-EPY_BYDuxfSBMw8G3PRmae2Z4NVm_n5v_2vW6hG51_jd-1AnEbbdjqDrraZtxc3kW_W7bmBtcO-6XR0uBF_ausoKDCx-VsBqYdFOQJbpaVBm0K1d6YgzD4VcXXuFwH4GNw93GgAy3sUSDvDqVlhU1LOIy_lUVll7jbA7uHvl7IwO-jzaqu7AOE_Swzl1JbT3iYGiPhqYlMDHVaS2l0hEgPCmU6bnafIuREhRiBVKgWSAqApAKQlIzQy9U9s5aZ5NzW7z3WVi09q3goqOdHqlNSKuGePdBIWtiC5Qm4ckLkjjhCHUzCUujmVo811am6Rq2BFqFnq2r4L37nSVe2Pg1t0pSC3RURygYIH3RoWFOVx4HuXHAKloJF6FUvC-uX_3vAD8_v61N0bffg81iN9yb7j9B16iXUxymNttDmYn5qH6Mr5seibOZPgohjdHjRMvIXKBKP-w
linkToPdf	http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V1bb9MwFLbGuIgX7ojCACPBE0SNHTuxkRACRsW0qeoDSHszjmNvEVNSmg4oP41fx7GTtMok9rYH3iLbTZzmOzf7-DsIPQcPArqIjrTVOmKZkFEuCxLxgpnEpdo6G0hcD7LpVBweytkW-tOfhfFplb1ODIq6qI1fIx9TLigT4D-TsevSIma7k7fz75GvIOV3WvtyGi1E9u3qJ4RvzZu9XfjWLyidfPz84VPUVRiIDCfZEmYkuKSaE0sKcJxTQrQRwqWg2TWNc2ZybmPptHFEgyg4ljuus1ymDC4tyxK47yV0OfOk5SFtcLZZ3-GemT7pzunEiRg3jDCI1XxOhD-YwSM5sIWhZMDAzz2bpXlmqzZYwMnN__m_u4VudH43ftcKym20Zas76GpbiXN1F_1uWZwbXDvsl0xLg5f1r7KChgofl_M5mHxQnCe4WVUatCx0eyMPQuJXG1_jcpOYjyEMwIEmtLBHgdQ7tJYVNi0RMf5WFpVd4W5v7B76ciEvfh9tV3VlHyDso89cSm09EWJijIS7xjI21GktpdEjRHqAKNNxtvvSIScq5A4kQrWgUgAqFUCl5Ai9XP9m3jKWnDv6vcfdeqRnGw8N9eJIdcpLxdyzChpJC1uwPAYXT4jcEUeog-AsgWnu9LhTnQps1AZ0I_Rs3Q3fxe9I6crWp2FMklCwx2KEsgHaBxMa9lTlcaBBF5yCBWEj9KqXi83D__3CD8-f61N0DURDHexN9x-h69QLq09fSnfQ9nJxah-jK-bHsmwWT4K0Y_T1okXkL0-3mMk
openUrl	ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Effects+of+uremic+toxins+on+hippocampal+synaptic+transmission%3A+implication+for+neurodegeneration+in+chronic+kidney+disease&rft.jtitle=Cell+death+discovery&rft.au=Natale%2C+Giuseppina&rft.au=Calabrese%2C+Valeria&rft.au=Marino%2C+Gioia&rft.au=Campanelli%2C+Federica&rft.date=2021-10-16&rft.pub=Nature+Publishing+Group+UK&rft.eissn=2058-7716&rft.volume=7&rft.issue=1&rft_id=info:doi/10.1038%2Fs41420-021-00685-9&rft.externalDocID=10_1038_s41420_021_00685_9
thumbnail_l	http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2058-7716&client=summon
thumbnail_m	http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2058-7716&client=summon
thumbnail_s	http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2058-7716&client=summon